Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free LABS Stock Alerts

MediPharm Labs (LABS) Competitors

MediPharm Labs logo
C$0.08 0.00 (0.00%)
As of 03:53 PM Eastern
Compare

LABS vs. TGOD, NINE, DB, WMD, and HEXO

Should you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), Decibel Cannabis (DB), WeedMD (WMD), and HEXO (HEXO). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does MediPharm Labs compare to Green Organic Dutchman?

Green Organic Dutchman (TSE:TGOD) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

0.3% of MediPharm Labs shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Green Organic Dutchman's average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score.

Company Overall Sentiment
Green Organic Dutchman Neutral
MediPharm Labs Neutral

Green Organic Dutchman has a net margin of 0.00% compared to MediPharm Labs' net margin of -18.32%. Green Organic Dutchman's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Green Organic DutchmanN/A N/A N/A
MediPharm Labs -18.32%-21.10%-7.17%

MediPharm Labs has higher revenue and earnings than Green Organic Dutchman. MediPharm Labs is trading at a lower price-to-earnings ratio than Green Organic Dutchman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Green Organic DutchmanC$31.37M0.00-C$137.58M-C$0.26N/A
MediPharm LabsC$45.12M0.80-C$12.05M-C$0.02N/A

Summary

MediPharm Labs beats Green Organic Dutchman on 5 of the 9 factors compared between the two stocks.

How does MediPharm Labs compare to Delta 9 Cannabis?

Delta 9 Cannabis (CVE:NINE) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

0.3% of MediPharm Labs shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Delta 9 Cannabis' average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score.

Company Overall Sentiment
Delta 9 Cannabis Neutral
MediPharm Labs Neutral

Delta 9 Cannabis has a net margin of 0.00% compared to MediPharm Labs' net margin of -18.32%. Delta 9 Cannabis' return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Delta 9 CannabisN/A N/A N/A
MediPharm Labs -18.32%-21.10%-7.17%

Delta 9 Cannabis has higher earnings, but lower revenue than MediPharm Labs. MediPharm Labs is trading at a lower price-to-earnings ratio than Delta 9 Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delta 9 CannabisC$12.87M6.94C$4.69MC$0.0519.07
MediPharm LabsC$45.12M0.80-C$12.05M-C$0.02N/A

Summary

Delta 9 Cannabis beats MediPharm Labs on 7 of the 10 factors compared between the two stocks.

How does MediPharm Labs compare to Decibel Cannabis?

MediPharm Labs (TSE:LABS) and Decibel Cannabis (CVE:DB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

0.3% of MediPharm Labs shares are owned by institutional investors. Comparatively, 0.7% of Decibel Cannabis shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by insiders. Comparatively, 1.1% of Decibel Cannabis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Decibel Cannabis has a net margin of -3.78% compared to MediPharm Labs' net margin of -18.32%. Decibel Cannabis' return on equity of -1.05% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-18.32% -21.10% -7.17%
Decibel Cannabis -3.78%-1.05%3.04%

Decibel Cannabis has a consensus target price of C$0.10, indicating a potential downside of 20.00%. Given Decibel Cannabis' stronger consensus rating and higher probable upside, analysts plainly believe Decibel Cannabis is more favorable than MediPharm Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MediPharm Labs
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Decibel Cannabis
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Decibel Cannabis has higher revenue and earnings than MediPharm Labs. Decibel Cannabis is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$45.12M0.80-C$12.05M-C$0.02N/A
Decibel CannabisC$112.72M0.64-C$1.03M-C$0.01N/A

MediPharm Labs has a beta of -0.383492, suggesting that its share price is 138% less volatile than the S&P 500. Comparatively, Decibel Cannabis has a beta of 0.067304, suggesting that its share price is 93% less volatile than the S&P 500.

In the previous week, MediPharm Labs' average media sentiment score of 0.00 equaled Decibel Cannabis'average media sentiment score.

Company Overall Sentiment
MediPharm Labs Neutral
Decibel Cannabis Neutral

Summary

Decibel Cannabis beats MediPharm Labs on 10 of the 13 factors compared between the two stocks.

How does MediPharm Labs compare to WeedMD?

WeedMD (CVE:WMD) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, WeedMD's average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score.

Company Overall Sentiment
WeedMD Neutral
MediPharm Labs Neutral

0.3% of MediPharm Labs shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

MediPharm Labs has higher revenue and earnings than WeedMD. MediPharm Labs is trading at a lower price-to-earnings ratio than WeedMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WeedMDC$27.53M2.46-C$102.60M-C$0.42N/A
MediPharm LabsC$45.12M0.80-C$12.05M-C$0.02N/A

WeedMD has a net margin of 0.00% compared to MediPharm Labs' net margin of -18.32%. WeedMD's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
WeedMDN/A N/A N/A
MediPharm Labs -18.32%-21.10%-7.17%

Summary

WeedMD and MediPharm Labs tied by winning 5 of the 10 factors compared between the two stocks.

How does MediPharm Labs compare to HEXO?

HEXO (TSE:HEXO) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

MediPharm Labs has a net margin of -18.32% compared to HEXO's net margin of -220.13%. MediPharm Labs' return on equity of -21.10% beat HEXO's return on equity.

Company Net Margins Return on Equity Return on Assets
HEXO-220.13% -106.39% -14.96%
MediPharm Labs -18.32%-21.10%-7.17%

In the previous week, HEXO's average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score.

Company Overall Sentiment
HEXO Neutral
MediPharm Labs Neutral

HEXO has a beta of 2.13, suggesting that its share price is 113% more volatile than the S&P 500. Comparatively, MediPharm Labs has a beta of -0.383492, suggesting that its share price is 138% less volatile than the S&P 500.

MediPharm Labs has lower revenue, but higher earnings than HEXO. MediPharm Labs is trading at a lower price-to-earnings ratio than HEXO, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HEXOC$124.10M0.00-C$273.18M-C$3.41N/A
MediPharm LabsC$45.12M0.80-C$12.05M-C$0.02N/A

7.6% of HEXO shares are owned by institutional investors. Comparatively, 0.3% of MediPharm Labs shares are owned by institutional investors. 3.0% of HEXO shares are owned by insiders. Comparatively, 4.5% of MediPharm Labs shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

MediPharm Labs beats HEXO on 6 of the 10 factors compared between the two stocks.

Get MediPharm Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

Export
MetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$36.11MC$1.63BC$6.24BC$11.72B
Dividend YieldN/A2.97%2.73%6.22%
P/E Ratio-4.254.1829.0423.83
Price / Sales0.801,488.53477.1013.46
Price / Cash1.3010.3727.6282.69
Price / Book1.0010.729.674.48
Net Income-C$12.05MC$21.15BC$3.55BC$300.68M
7 Day PerformanceN/A-1.16%1.70%0.12%
1 Month PerformanceN/A0.17%5.62%2.88%
1 Year PerformanceN/A24.19%34.42%57.78%

MediPharm Labs Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
MediPharm Labs
N/AC$0.09
flat		N/AN/AC$36.11MC$45.12MN/A130
TGOD
Green Organic Dutchman
N/AN/AN/AN/AC$89.95MC$31.37MN/A41
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%		N/AN/AC$89.36MC$12.87M19.07940
DB
Decibel Cannabis
0.041 of 5 stars		C$0.13
flat		C$0.10
-23.1%		N/AC$74.99MC$112.72MN/A83,000
WMD
WeedMD
N/AC$0.28
-1.8%		N/AN/AC$67.82MC$27.53MN/A628

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:LABS) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel